Who is the CEO of JPI Healthcare?

According to the DART company overview, JPI Healthcare's representative director is 김진국 (name as registered in Korean). The company was founded on 1980-12-22.

Where is JPI Healthcare listed?

JPI Healthcare trades on the Korea Exchange KOSDAQ market under the ticker 0010V0. Its fiscal year ends in December.

Does JPI Healthcare pay a dividend?

Yes. For fiscal 2025, JPI Healthcare paid a cash dividend of ₩250 per common share, a 1.7% yield as stated in its annual report, with a payout ratio of 26.3%. The prior year's dividend was ₩160.

Does JPI Healthcare have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Profit +50% (latest quarterly operating profit up more than 50% year on year). These are factual flags, not investment advice.

Which companies are in the same industry as JPI Healthcare?

Under the Korean Standard Industrial Classification recorded on DART, JPI Healthcare is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.

JPI Healthcare KRX:0010V0KOSDAQ

제이피아이헬스케어 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days6

DART filings, 7 days0

Articles tracked7since Sep 11

In Q2 2026, JPI Healthcare reported revenue of ₩12.0bn, down 8.5% year on year, and operating profit of ₩2.1bn. JPI Healthcare (제이피아이헬스케어) appeared in 6 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 27 with 4 articles. The most common catalyst was tech & capacity (1). It was most often mentioned alongside Samsung Electronics.

Filing signals Profit +50% Screener

JPI Healthcare quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩12.0bn	-8.5%	₩2.1bn margin 18.0%	₩2.5bn
Q1 2026	₩10.8bn	-4.4%	₩458m margin 4.3%	₩1.6bn
Q4 2025 derived	₩12.3bn	-3.6%	₩1.4bn margin 11.6%	₩1.6bn
Q3 2025	₩11.9bn	+15.8%	₩660m margin 5.6%	₩1.1bn
Q2 2025	₩13.1bn	+17.9%	₩1.3bn margin 10.1%	₩687m
Q1 2025	₩11.3bn	–	₩1.5bn margin 12.9%	₩1.4bn
Q4 2024 derived	₩12.7bn	–	₩1.8bn margin 14.3%	₩2.6bn
Q3 2024	₩10.2bn	–	₩183m margin 1.8%	−₩193m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

JPI Healthcare top stories 2 weeks, by number of outlets

1
제이피아이헬스케어, 산업통상부-삼성전자 기술나눔 특허 양수기업 선정
3 outlets · 3 articlesFirst report Oct 27 09:00 한스경제Samsung Electronics
2
제이피아이헬스케어, 삼성전자 모바일 엑스선 특허 확보
1 outlets · 1 articlesFirst report Oct 27 15:01 뉴스1New technologySamsung Electronics
3
제이피아이헬스케어, 삼성전자 모바일 엑스선 특허 이전 대상 선정
1 outlets · 1 articlesFirst report Oct 26 15:44 바이오타임즈Samsung Electronics
4
JPI헬스케어, 삼성전자 모바일 X-선 특허 기술 확보
1 outlets · 1 articlesFirst report Oct 26 16:02 라포르시안Samsung Electronics

Latest JPI Healthcare news Korean headlines

Oct 2715:01

Major제이피아이헬스케어, 삼성전자 모바일 엑스선 특허 확보
뉴스1New technologySamsung Electronics
Oct 2709:00
제이피아이헬스케어, 산업통상부-삼성전자 기술나눔 특허 양수기업 선정
한스경제Samsung Electronics
2 more on this story · 2 outlets
- 제이피아이헬스케어, 산업통상부-삼성전자 기술나눔 모바일 엑스선 특허 양수기업 선정파이낸스투데이 · Oct 27 09:00
- 제이피아이헬스케어, 산업통상부-삼성전자 기술나눔 통해 모바일 엑스선 특허 1건 양수기업으로 선정테크월드 · Oct 27 09:10
Oct 2616:02

JPI헬스케어, 삼성전자 모바일 X-선 특허 기술 확보
라포르시안Samsung Electronics
Oct 2615:44

제이피아이헬스케어, 삼성전자 모바일 엑스선 특허 이전 대상 선정
바이오타임즈Samsung Electronics
Oct 813:34

[르포] ‘46년째 웰메이드로 승부’ 제이피아이헬스케어 안산 공장, 그리드 생산 현장 가보니
동아일보

Articles per day 2 weeks

226

427

Company profile

CEO: 김진국
Industry: Medical devices
Founded: 1980-12-22
Fiscal year-end: December
Head office: 서울특별시 구로구
Website: jpi-korea.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

JPI Healthcare dividends annual report

Korea dividend rankings

Year	Per share	Yield	Payout
FY2025	₩250	1.7%	26.3%
FY2024	₩160	–	25.9%
FY2023	₩350	–	23.0%

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
Seers	₩12.9bn	76
Sky Labs	–	71
Medyssey	–	47
InBody	₩17.7bn	29
Cosmo Robotics	−₩3.3bn	24
Finemedix	₩790m	23
Dynamic solution	−₩950m	20
Hironic	₩1.1bn	19

Compare JPI Healthcare side by side with these companies

JPI Healthcare DART filings

No filings yet.

Catalysts 2 weeks

Tech & capacity1

Mentioned alongside 2 weeks

1 Samsung ElectronicsKOSPI 6

JPI Healthcare FAQ

Who is the CEO of JPI Healthcare?: According to the DART company overview, JPI Healthcare's representative director is 김진국 (name as registered in Korean). The company was founded on 1980-12-22.
Where is JPI Healthcare listed?: JPI Healthcare trades on the Korea Exchange KOSDAQ market under the ticker 0010V0. Its fiscal year ends in December.
What were JPI Healthcare's latest quarterly results?: In Q2 2026, JPI Healthcare reported revenue of ₩12.0bn, down 8.5% year on year, and operating profit of ₩2.1bn. Figures come from reports filed on DART.
Does JPI Healthcare pay a dividend?: Yes. For fiscal 2025, JPI Healthcare paid a cash dividend of ₩250 per common share, a 1.7% yield as stated in its annual report, with a payout ratio of 26.3%. The prior year's dividend was ₩160.
Does JPI Healthcare have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Profit +50% (latest quarterly operating profit up more than 50% year on year). These are factual flags, not investment advice.
Which companies are in the same industry as JPI Healthcare?: Under the Korean Standard Industrial Classification recorded on DART, JPI Healthcare is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.